Slope Clinical

Clinical trial execution platform.

About

Founded

2016

Headquarters

San Francisco, California

Industry

Healthcare

Company Description

Slope provides a clinical trial execution platform for sponsors and research sites collaborating on complex, sample-intensive clinical trials. The platform reduces operational chaos for sponsors, CROs, research sites, and labs by providing data-driven oversight into clinical trial activities. Through Slope’s clinical inventory, sample management, and data-driven resupply solutions, the platform enables stakeholder collaboration, real-time visibility, traceable chain of custody, and risk mitigation. This results in improved trial outcomes — including boosting patient enrollment and retention — reduction of supply waste, and adherence to study protocols, timelines, and budgets.

Quick Links

WebsiteJobs

Funding

Total Raised

$23 million

Valuation

Undisclosed

Significant Investors

New Enterprise Associates

Company Traction

  • As of June 2023, Slope reported 13,000+ studies supported, 1.7 million supplies managed, and 1,100 slope-enabled sites.
  • As of June 2023, Slope reported 34% savings, zero study delays due to sample loss, and 100% sample integrity.
  • Slope customers include Lumabridge, Parker Institute for Cancer Immunotherapy, Cyteir Therapeutics, Harbinger Health, and Proxima Clinical Research.

Leadership Team

  • Rust Felix: Co-Founder & CEO of Slope Clinical. Former President at APHID Industries.
  • Michael Felix: Co-Founder & CTO of Slope Clinical. Former Co-Founder & CTO of APHID Industries.
  • Hope Meely: Chief Clinical Officer at Slope Clinical. Former VP of Clinical Operations at Prelude Therapeutics.
  • Ben Carmel: CRO at Slope Clinical. Former VP of Global Sales at H1.
  • Benjamin Meador: CFO at Slope Clinical. Former Director, IT Financial Operations at Envision Healthcare.